Track topics on Twitter Track topics that are important to you
NEALS is a non-profit organization that aims to successfully promote both research and awareness of ALS, encouraging collaborations among clinicians, researchers, and industry through a commitment to open scientific communication. The efforts of NEALS members are recognized by disease foundations, research groups, and industry, generating critical support through awards and project funding. Bringing together a group of distinguished scientists and researchers over the nearly quarter century since its inception, NEALS has developed novel research approaches and recruited a number of new investigators into the field of ALS research in an effort to accelerate ALS clinical trials through academic input and partnership. The NEALS Consortium adheres to an inclusive policy of adding clinical sites wherever there is interest and expertise, improving access to trials in regions where trial participation was not previously available. NEALS sites include 127 academic ALS trial centers in the United States, Canada, Mexico, Lebanon, Italy, Australia and Israel.Annual Clinical Research Learning InstitutePALS & CALS as Research AmbassadorsAdvocacy efforts by Research AmbassadorsNEALS website & clinical trial database: http://www. neals.org The numerous trials run by NEALS-affiliated Principal Investigators and/or Centers is used as a broad benchmark of success for the Consortium. Additionally, the growth of participation in studies by people with ALS has been used as a similar outcome measure when assessing the success of the organization. The research done by NEALS members, paired with the membership's commitment to a coordinated effort, give the NEALS Consortium a unique role, one with top credibility in the community of people with ALS (PALS). The strong relationship between the Consortium's research members and PALS is substantiated by the increasing participation of PALS in the organization's research efforts. Since 1999, 125,286 PALS have participated in NEALS studies. In 2018 alone, 4,173 people with ALS participated in NEALS trials, up significantly from 1999's participation (n=101). It is more critical than ever for healthcare professionals to underscore the importance of clinical research into the causes and treatments of ALS and associated conditions. In this vision for the future, by involving more people in ALS research and ensuring that they and those around them are properly informed about the disease, public knowledge regarding rare disease research grows, allowing the research community to give back to the patient population through science breakthroughs and increased disease knowledge.
This article was published in the following journal.
Name: Amyotrophic lateral sclerosis & frontotemporal degeneration
Collaboration is the cornerstone of nowadays research. Successful collaborative research and high research quality go hand in hand. Collaborative research needs to build on common and upfront expectat...
A genetic basis is found in ∼70% of familial and ∼15% of sporadic ALS, in research cohorts. Clinical trials of gene-targeted therapies are underway, heralding a new era of personalized medicine in...
The Research Electronic Data Capture (REDCap) data management platform was developed in 2004 to address an institutional need at Vanderbilt University, then shared with a limited number of adopting si...
The Extracellular RNA Communication Consortium (ERCC) was launched to accelerate progress in the new field of extracellular RNA (exRNA) biology and to establish whether exRNAs and their carriers, incl...
The German Center for Lung Research (DZL) is a research network with the aim of researching respiratory diseases. In order to enable consortium-wide retrospective research and prospective patient recr...
Frontotemporal Lobar Degeneration (FTLD) is the neuropathological term for a collection of rare neurodegenerative diseases that correspond to four main overlapping clinical syndromes: fro...
Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary ...
The Mood Disorder Cohort Research Consortium (MDCRC) study is designed as a naturalistic observational prospective cohort study for early-onset mood disorders (major depressive disorders, ...
The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic ...
The ACIC is a Collaborative Quality Improvement (CQI) program involving the collection of data related to: indications for Coronary Computed Tomography (CCTA), patient health characteristi...
Collaborative process of research involving researchers and community representatives.
WHO regional office for the Americas acting as a coordinating agency for the improvement of health conditions in the hemisphere. The four main functions are: control or eradication of communicable diseases, strengthening of national and local health services, education and training, and research.
Component of the NATIONAL INSTITUTES OF HEALTH. It seeks to improve oral, dental and craniofacial health through research, research training, and the dissemination of health information by conducting and supporting basic and clinical research. It was established in 1948 as the National Institute of Dental Research and re-named in 1998 as the National Institute of Dental and Craniofacial Research.
A designation for publications of research resulting from extramural research funded by the National Institutes of Health.
The moral obligations governing the conduct of research. Used for discussions of research ethics as a general topic.
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...